Microbot Medical Stock Today
| MBOT Stock | USD 1.67 0.04 2.34% |
PerformanceOK
| Odds Of DistressBelow Average
|
Microbot Medical is selling for under 1.67 as of the 19th of March 2025; that is 2.34 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 1.67. Microbot Medical has about a 36 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 19th of December 2024 and ending today, the 19th of March 2025. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 25th of March 1992 | Category Healthcare | Classification Health Care |
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts. The company has 34.74 M outstanding shares of which 4.76 M shares are now shorted by private and institutional investors with about 1.51 trading days to cover. More on Microbot Medical
Moving against Microbot Stock
Microbot Stock Highlights
| Chairman | Harel Gadot | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Drugs, Office Supplies, Pharmaceutical Products, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsMicrobot Medical can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Microbot Medical's financial leverage. It provides some insight into what part of Microbot Medical's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Microbot Medical (MBOT) is traded on NASDAQ Exchange in USA. It is located in 288 Grove Street, Braintree, MA, United States, 02184 and employs 21 people. Microbot Medical is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 59.41 M. Microbot Medical conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 34.74 M outstanding shares of which 4.76 M shares are now shorted by private and institutional investors with about 1.51 trading days to cover.
Microbot Medical currently holds about 9.29 M in cash with (8.53 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.31.
Check Microbot Medical Probability Of Bankruptcy
Ownership AllocationMicrobot Medical maintains a total of 34.74 Million outstanding shares. Roughly 90.91 % of Microbot Medical outstanding shares are held by general public with 1.62 pct. owned by insiders and only 7.47 % by institutional investors. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Microbot Ownership Details
Microbot Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Two Sigma Securities, Llc | 2024-12-31 | 10.7 K | |
| Stifel Financial Corp | 2024-12-31 | 10.3 K | |
| Bb&t Corp. | 2024-12-31 | 10 K | |
| Diamant Asset Management Inc | 2024-12-31 | 10 K | |
| Wells Fargo & Co | 2024-12-31 | 8.9 K | |
| Beacon Capital Management, Llc | 2024-12-31 | 6 K | |
| Bfsg, Llc | 2024-12-31 | 5.5 K | |
| Tower Research Capital Llc | 2024-12-31 | 4.4 K | |
| Sbi Securities Co Ltd | 2024-12-31 | 3 K | |
| Vanguard Group Inc | 2024-12-31 | 459.5 K | |
| Geode Capital Management, Llc | 2024-12-31 | 142.7 K |
Microbot Medical Historical Income Statement
Microbot Stock Against Markets
Microbot Medical Corporate Executives
Elected by the shareholders, the Microbot Medical's board of directors comprises two types of representatives: Microbot Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Microbot. The board's role is to monitor Microbot Medical's management team and ensure that shareholders' interests are well served. Microbot Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Microbot Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Additional Tools for Microbot Stock Analysis
When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.